196 related articles for article (PubMed ID: 8832501)
61. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes.
Mendonça EA; Lira MC; Rabello MM; Cavalcanti IM; Galdino SL; Pitta IR; Lima Mdo C; Pitta MG; Hernandes MZ; Santos-Magalhães NS
AAPS PharmSciTech; 2012 Dec; 13(4):1355-66. PubMed ID: 23054982
[TBL] [Abstract][Full Text] [Related]
62. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
63. Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl-beta-cyclodextrin model case.
Sideris EE; Koupparis MA; Macheras PE
Pharm Res; 1994 Jan; 11(1):90-5. PubMed ID: 8140060
[TBL] [Abstract][Full Text] [Related]
64. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins.
De Gaetano F; Cristiano MC; Paolino D; Celesti C; Iannazzo D; Pistarà V; Iraci N; Ventura CA
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421730
[TBL] [Abstract][Full Text] [Related]
65. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
Miyake K; Arima H; Irie T; Hirayama F; Uekama K
Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664
[TBL] [Abstract][Full Text] [Related]
66. Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
Ventura P; Panini R; Montosi G; Garuti C; Vandelli M; Brunetti G; Tauschel H; Pietrangelo A; Salvioli G
Pharmacology; 2001 Feb; 62(2):107-12. PubMed ID: 11174081
[TBL] [Abstract][Full Text] [Related]
67. Computational investigation of enthalpy-entropy compensation in complexation of glycoconjugated bile salts with β-cyclodextrin and analogs.
Tidemand KD; Schönbeck C; Holm R; Westh P; Peters GH
J Phys Chem B; 2014 Sep; 118(37):10889-97. PubMed ID: 25158050
[TBL] [Abstract][Full Text] [Related]
68. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose.
Wang Z; Horikawa T; Hirayama F; Uekama K
J Pharm Pharmacol; 1993 Nov; 45(11):942-6. PubMed ID: 7908033
[TBL] [Abstract][Full Text] [Related]
69. Effect of 2,6-di-O-methyl-alpha-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells.
Motoyama K; Arima H; Toyodome H; Irie T; Hirayama F; Uekama K
Eur J Pharm Sci; 2006 Oct; 29(2):111-9. PubMed ID: 16870405
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, spectroscopy, theoretical and biological studies of new gramine-steroids salts and conjugates.
Kozanecka W; Mrówczyńska L; Pospieszny T; Jasiewicz B; Gierszewski M
Steroids; 2015 Jun; 98():92-9. PubMed ID: 25777948
[TBL] [Abstract][Full Text] [Related]
71. Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins.
Ono N; Miyamoto Y; Ishiguro T; Motoyama K; Hirayama F; Iohara D; Seo H; Tsuruta S; Arima H; Uekama K
J Pharm Sci; 2011 May; 100(5):1935-43. PubMed ID: 21374625
[TBL] [Abstract][Full Text] [Related]
72. Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: in vitro/in vivo studies.
Cappello B; Carmignani C; Iervolino M; Immacolata La Rotonda M; Fabrizio Saettone M
Int J Pharm; 2001 Feb; 213(1-2):75-81. PubMed ID: 11165095
[TBL] [Abstract][Full Text] [Related]
73. Synthesis and haemolytic activity of novel salts made of nicotine alkaloids and bile acids.
Jasiewicz B; Mrówczyńska L; Malczewska-Jaskóła K
Bioorg Med Chem Lett; 2014 Feb; 24(4):1104-7. PubMed ID: 24461290
[TBL] [Abstract][Full Text] [Related]
74. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
[TBL] [Abstract][Full Text] [Related]
75. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse.
Brewster ME; Anderson WR; Loftsson T; Huang MJ; Bodor N; Pop E
J Pharm Sci; 1995 Oct; 84(10):1154-9. PubMed ID: 8801327
[TBL] [Abstract][Full Text] [Related]
76. Determination of related impurities of bile acids in bulk drugs by cyclodextrin-modified micellar electrokinetic chromatography.
Lucangioli SE; Rodríguez VG; Fernández Otero GC; Carducci CN
J Capillary Electrophor; 1998; 5(3-4):139-42. PubMed ID: 10797879
[TBL] [Abstract][Full Text] [Related]
77. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
Sharma US; Balasubramanian SV; Straubinger RM
J Pharm Sci; 1995 Oct; 84(10):1223-30. PubMed ID: 8801338
[TBL] [Abstract][Full Text] [Related]
78. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
79. Structure-retention correlation of isomeric bile acids in inclusion high-performance liquid chromatography with methyl beta-cyclodextrin.
Momose T; Yamaguchi Y; Iida T; Goto J; Nambara T
Lipids; 1998 Jan; 33(1):101-8. PubMed ID: 9470179
[TBL] [Abstract][Full Text] [Related]
80. Inhibitory effect of 2-hydroxypropyl-beta-cyclodextrin on crystal-growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30.
Uekama K; Ikegami K; Wang Z; Horiuchi Y; Hirayama F
J Pharm Pharmacol; 1992 Feb; 44(2):73-8. PubMed ID: 1352820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
